Tango Therapeutics Inc (TNGX)
Healthcare
Biotechnology
—
27.20 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Tango Therapeutics Inc (TNGX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 42.7% of the shares are freely tradable; institutional investors hold 113.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
113.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
42.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
21.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
163Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RTW INVESTMENTS, LLC | 9.20 | 13,300,620 | +791.9 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 8.86 | 12,809,485 | +20.8 | 03/31/2026 |
| Boxer Capital Management, LLC | 7.52 | 10,876,219 | +0.0 | 03/31/2026 |
| TCG Crossover Management, LLC | 7.28 | 10,531,071 | -17.5 | 03/31/2026 |
| FMR Inc | 6.85 | 9,905,919 | +245.4 | 03/31/2026 |
| Farallon Capital Management, L.L.C. | 6.29 | 9,097,411 | -30.3 | 03/31/2026 |
| BlackRock Inc | 6.05 | 8,748,045 | +2.4 | 03/31/2026 |
| Woodline Partners LP | 5.53 | 8,000,013 | -20.6 | 03/31/2026 |
| Nextech Invest, Ltd. | 5.02 | 7,266,081 | +31.3 | 12/31/2025 |
| Vanguard Group Inc | 4.67 | 6,750,977 | +33.6 | 12/31/2025 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.